Abstract:Introduction: Left ventricular assist device (LVAD) implantation is a viable therapy for patients with severe end-stage heart failure, providing effective haemodynamic support and improved quality of life. The Heart Assist 5 (Micromed Cardiovascular Inc, Houston, TX) continuous-flow LVAD has been on the market in Europe since May 2009. Methods: We evaluated nine Heart Assist 5 LVAD patients with two- and three-dimensional transthoracic echocardiographic (TTE) and transoesophageal echocardiographic (TEE) parameters between December 2011 and December 2013. The pre-operative TTE LVAD evaluations included left ventricular (LV) function and structure, quantification of right ventricular (RV) function and tricuspid regurgitation (TR), assessment of aortic and mitral regurgitation, and presence of patent foramen ovale and intra-cardiac clots. Peri-operative TEE determined the inflow cannula and septum position, and assessed the de-airing process while weaning from cardiopulmonary bypass. Post-operative serial follow-up TTE showed the surgical results of LVAD implantation, determined the overall structure and function of the LV, RV and TR, and observed the inflow and outflow cannula position. Results: Nine patients who had undergone Heart Assist 5 LVAD implantation and had been followed up for more than 30 days were included in this study. Eight patients had ischaemic cardiomyopathy and one had adriamycin-induced cardiomyopathy. Pre-implantation data: the mean age of the patients was 52 ± 13 (34-64) years, mean body surface area (BSA) was 1.8 ± 0.2 (1.6-2.0) m2, mean cardiac index (CI) was 2.04 ± 0.4 (1.5-2.6) l/min/m2, mean cardiac output (CO) was 3.7 ± 0.7 (2.6-4.2) l/min, mean ejection fraction (EF) was 23 ± 5 (18-28)%, and right ventricular fractional area contraction (RVFAC) was 43 ± 9 (35-55)%. One patient had aortic valve replacement (AVR) during the LVAD implantation, and excess current alarms and increased power were suspected to be caused by a possible thrombus. Close follow up with TTE studies were carried out to clear the LV of thrombus formation, and the inflow cannula position was checked to maintain the septum in the midline, so preventing the suction cascade. Four patients were followed up for more than two years, and two were followed up for more than a year. Three patients died due to multi-organ failure. Follow-up speed-change TTE studies of six patients showed that the mean speed was 9 800 ± 600 (9 500-10 400) rpm, and mean CO was 4.7 ± 0.3 (4.3-5.0) l/min during the three-month post-implant period. Conclusion: We believe that TTE can play a major role in managing LVAD patients to achieve optimal settings for each patient. A large series is mandatory for assessment of echocardiographic studies on Heart Assist 5 LVAD.

Surgical Training Improves Performance in Minimally Invasive Left Ventricular Assist Device Implantation Without Cardiopulmonary Bypass.

Experimental Study of Domestic Emplantable Ventricular Assist Device

Establishment of an Animal Model for Implantable Ventricular Assist Device

Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis

Experience with porcine beating heart simulator for coronary artery bypass surgery residency training

Video assisted application in minimally invasive cardiac surgery

Implantation of Left Ventricular Leads Using a Telescopic Catheter System

In Vivo Testing of a Second-Generation Prototype Accessory for Single Transapical Left Ventricular Assist Device Implantation

Improving Hemodynamics of Cardiovascular System under a Novel Intraventricular Assist Device Support Via Modeling and Simulations

Clinical Translation of Surgical Simulated Closure of a Ventricular Septum Defect.

Initial experience and favorable outcomes on cannulation strategies and surgical platform construction in fully video-assisted thoracoscopic cardiac surgery

Early Assistance with Left Ventricular Assist Device Limits Left Ventricular Remodeling after Acute Myocardial Infarction in a Swine Model.

CH‐VAD left ventricular assist implantation combined with the Bentall procedure and coronary artery bypass grafting

Less Invasive Implantation Of Third Generation Left Ventricular Assist Devices: Preliminary Analysis

Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography

[The Left Ventricular Assistance Device Was Used for Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery in Perioperative Period].

Total endoscopic robot-assisted on-pump cardiac surgery:preliminary experience with robot-assisted surgery

Enhancing the implantation of mechanical circulatory support devices using computational simulations

Percutaneous Ventricular Restoration Prevents Left Ventricular Remodeling Post Myocardial Infarction: One-Year Evaluation of the Heartech First-in-man Study

Surgical skill simulation training to proficiency reduces procedural errors among novice cardiac device implanters: a randomized study

Perfecting The Seemingly Normal; Preoperative Optimization